Obinutuzumab in Primary MN

NCT05050214 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Membranous Nephropathy

Interventions

DRUG: Obinutuzumab

Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

[object Object]